Pay in 4 interest-free payments of $7.34 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Legal Disclaimer: This product is sold strictly for laboratory research purposes and is intended only for use by qualified researchers or licensed professionals
That is where regenerative medicine comes in
The July 23 PCAC meeting will evaluate its eligibility for the 503A Bulks List before FDA makes a final decision
Models of tendon injury, assessment of the proliferation and migration of tendon fibroblasts and activation of the FAK-paxillin pathway (Chang et al
Related Protocols Cards linking to related compounds and stacks
10.2174/13816128130111 128 SikiricP.SeparovicJ.AnicT.BuljatG.MikusD.SeiwerthS.et al (1999a)
US$ 25.51
US$ 27.15
US$ 20.77
US$ 25.05
US$ 25.46
US$ 27.77
